Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Gamida Cell
company
About
Gamida Cell is a biopharmaceutical company developing advanced cell therapies for patients with blood cancers and hematologic diseases.
- 101 - 250
Highlights
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- $16M
- Industries
- Biotechnology,Health Care,Life Science,Medical Device,Therapeutics
- Founded date
- Jan 1, 1998
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Gamida Cell is a biopharmaceutical company developing advanced cell therapies for patients with blood cancers and hematologic diseases. Its product includes NiCord, a cell therapy based on NAM-expanded cord blood developed to improve and extend the life-saving benefits of hematopoietic stem cell transplant. The company applies an expansion platform supporting the properties of NAM to allogeneic cell sources that include omidubicel, an investigational product with potential as a life-saving alternative for patients in need of bone marrow transplant.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$26M
Gamida Cell has raised a total of
$26M
in funding over 2 rounds. Their latest funding was raised on
May 15, 2012 from a Series E round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 15, 2012 | Series E | $10M | 1 | — | — | Detail |
| Sep 27, 2006 | Series D | $16M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Gamida Cell is funded by 2 investors.
Denali Ventures
and Elscint Biomedical Investment
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Denali Ventures
|
— | Series E |
|
|
— | Series D |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
